Research Article
Volume 11 Issue 6 - 2022
The Incidence and Clinical Characteristics of Pulmonary Embolism (PE) in Oncologic Patients: Cohort Study
Mohamed Abdelgwad Habeb1*, Mohamed Fouad Abdelmohsen2, Abdulmajeed Mualla Alotaibi3, Dhafer Abdullah Alshehri4, Ahmed Hamza Mohammed Alhadi5, Afaf Shuaib Albaqawi6, Abdullah Mansour Alassaf6 and Mohammed Rajeh Alshehri7
1Pulmonology Consultant, Ministry of Health KSA, Madinah, Saudi Arabia
2Lecturer of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Suez Canal University, Egypt and Senior Registrar of Medical Oncology, King Fahad Hospital, Almadinah, Saudi Arabia
3R4 Senior Internal Medicine Resident, Ministry of Interior-KSA, Riyadh, Saudi Arabia
4Registrar of Internal Medicine, Ministry of Interior-KSA, Riyadh, Saudi Arabia
5R4 Senior Internal Medicine Resident, Ministry of National Guard-Health Affairs, Madinah, Saudi Arabia
6Senior Resident Internal Medicine, Ministry of Health-KSA, Riyadh, Saudi Arabia
7R3 Senior Internal Medicine Resident, Ministry of Health-KSA, Riyadh, Saudi Arabia
*Corresponding Author: Mohamed Abdelgwad Habeb, Pulmonary Medicine, King Fahad Hospital, Almadinah, Saudi Arabia.
Received: June 22, 2022; Published: June 28, 2022




Abstract

Background: The clinical characteristics of pulmonary embolism (PE) in Oncological outpatients for different types of cancer are unknown.

Purpose of the Study: To estimate the incidence and type of pulmonary embolism among oncologic patients with an assessment of related clinical characteristics.

Patient and Methods: Prospective cohort study was carried out on (540) patients with different cancers at one day care unit of the oncology department at king Fahd hospital, Kingdom of Saudi Arabia. CT chest with contrast and CT pulmonary angiography was done when indicated.

Results: Our study was carried out on (540) patients who have different cancers, of which 24 (4.44%) developed PE. PE group was 9 (37.5%) males while 15 (62.5%) females with M ± SD of age (54.95 ± 17.3). PE was represented (50%) of patients with seminoma, germ cell tumor while larynx Cancer was represented (33.4%) and less common in colon, prostate, and breast Cancers (6.68%, 4.7%, 2.54%) respectively. 7 PE patients (1.3%) were incidentally discovered during the staging of cancer while 17 patients (3.14%) have symptomatic PE. In the symptomatic group: (10) patients developed PE during chemotherapy, (4) patients developed PE during hormonal therapy, (2) patients developed PE during the staging of cancer and (1) patients developed PE during follow-up after chemotherapy. 20/24 (84%) of PE developed in the first 6 months from diagnosis of cancer while 4/24 (16%) of PE developed during follow up of the patients within the first year from diagnosis patients had cancer prostrate, one patient has cancer larynx and one patient has cancer breast. The most degree of PE was low-risk PE (75%) while massive and sub-massive were in (3) patients (12.5%) each. Most of the patients were given low molecular weight heparin (LMWH) (22/24) patients while thrombolytic therapy (TPA) was given for only one patient and IVC filter was inserted in 2 patients.

Conclusion: Among oncological patients in outpatients' settings with Different Types of Cancers, PE incidence was 4.4% with Most common of these were seminoma, germ cell tumor, prostate, lung, and larynx cancers but the least common in Breast Cancer. Noted that patients with (lung, pancreas, uterus, and bladder) cancer have a higher risk of Incidental PE. Low-risk PE type was the most common, while sub-massive and Massive were rare.

Keywords: PE; Different Cancer Type; Characters; Oncology; Outpatient

References

  1. Griffiths GO., et al. “FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin {sup®} added to standard therapy in patients with lung cancer”. BMC Cancer (2009): 9.
  2. Lee AYY., et al. “Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer”. The New England Journal of Medicine2 (2003): 146-153.
  3. Bloom J., et al. “The risk of venous thrombosis in cancer patients with or without the factor V Leiden mutation”. Haemostasis1 (2001): 73.
  4. Zuckerman E., et al. “Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy”. British Journal of Cancer 2 (1995): 447-451.
  5. Perry JR., et al. “PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma”. Journal of Thrombosis and Haemostasis 9 (2010): 1959-1965.
  6. Chew HK., et al. “Incidence of venous thromboembolism and its effect on survival among patients with common cancers”. Archives of Internal Medicine 4 (2006): 458-464.
  7. Blom JW., et al. “High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients”. European Journal of Cancer 3 (2006): 410-414.
  8. Farrell C., et al. “Unsuspected pulmonary embolism identified using multidetector computed tomography in hospital outpatients”. Clinical Radiology 1 (2010): 1-5.
  9. Ghaye B., et al. “Can CT pulmonary angiography allow assessment of severity and prognosis in patients presenting with pulmonary embolism? What the radiologist needs to know”. Radiographics1 (2006): 23-39.
  10. Desai SR. “Unsuspected pulmonary embolism on CT scanning: yet another headache for clinicians? Thorax”. BMJ Publishing Group Ltd 62 (2007): 470-472.
  11. Konstantinides SV., et al. “2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of”. European Heart Journal 4 (2020): 543-603.
  12. Reynolds MW., et al. “Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: a systematic review and meta-analysis”. Current Medical Research and Opinion 2 (2008): 497-505.
  13. Khorana AA and Connolly GC. “Assessing risk of venous thromboembolism in the patient with cancer”. Journal of Clinical Oncology 29 (2009): 4839.
  14. Agnelli G., et al. “A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the@ RISTOS project”. Annals of Surgery 1 (2006): 89.
  15. Biedka M., et al. “Acute pulmonary embolus in the course of cancer”. Contemporary Oncology 5 (2012): 388-393.
  16. Stein PD., et al. “Incidence of venous thromboembolism in patients hospitalized with cancer”. The American Journal of Medicine 1 (2006): 60-68.
  17. Khorana AA., et al. “Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients”. Cancer10 (2007): 2339-2346.
  18. Karippot A., et al. “The clinical characteristics of pulmonary embolism in patients with malignancy: a single medical institutional experience”. North American Journal of Medical Sciences 11 (2012): 600-604.
  19. Abdel-Razeq HN., et al. “Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome--a comprehensive cancer center experience”. Vascular Health and Risk Management 7 (2011): 153-158.
  20. Dentali F., et al. “Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis”. Thrombosis Research 6 (2010): 518-522.
Citation: Mohamed Abdelgwad Habeb., et al. “The Incidence and Clinical Characteristics of Pulmonary Embolism (PE) in Oncologic Patients: Cohort Study”. EC Pulmonology and Respiratory Medicine 11.6 (2022): 44-49.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 09, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.